Investment income up 53.4% but portfolio swung to a $347.5m total loss

Investment income rose 53.4% to NZ$360.6m and NPAT lifted 53.4% to NZ$360.6m, both materially above Annolyse's historical baseline of NZ$297.1m three-period mean income. Profit before tax rose 50.8% to NZ$374.0m.

At the same time, investment total return swung from +NZ$1.5b to –NZ$347.5m, well below the historical range of NZ$797.2m–NZ$1.5b, as the benchmark total return fell to 5.1% from 29.1%. Net assets attributable dropped 7.5% to NZ$7b, below the historical mean of NZ$7.8b. The total dividend held flat at 24 cents fully franked, and gross borrowings stepped up from nil to NZ$10.0m.

• Strong income reflected dividends received from portfolio holdings, but mark-to-market and realised capital movements drove a NZ$347.5m total return loss versus +NZ$1.5b prior. For shareholders this matters because total return — not income alone — drives long-term NTA progression.

• Distribution coverage loosened sharply, but on a possibly elevated income base. Investment income covered the distribution at 163.2% versus 106% prior, and the NPAT payout ratio fell to 61.3% from 94.4%. That gives near-term distribution headroom, but only if portfolio dividend income is sustained; special and post-pandemic catch-up dividends from FY22 may not repeat.

• ROE rose to 5.0%, above the 3.1%–4.1% historical range, but on a shrinking equity base. The denominator fell 7.5% as net assets contracted, so the ROE lift partly reflects capital erosion rather than improved earning power on a stable book.

The interim shape suggests the second half was the heavier income period: HY22 contributed 44.9% of full-year investment income and 40.5% of full-year NPAT, implying roughly NZ$198.8m of income and NZ$214.6m of NPAT in the second half. That points to dividend receipts accelerating into June 2022 rather than a smooth distribution profile.

What the release does not support is any view on whether the elevated income run-rate is durable into FY23 if Australian corporate dividend payouts normalise after the FY22 surge.

Some of that lift will reflect special dividends and resumption payments after pandemic-period suspensions, which is not a recurring run-rate.

Two quality caveats sit beneath the headline NPAT. First, the effective tax rate of 3.6% is below the historical 5.2%–7.1% range and below the 5.2% prior, so PBT growth of 50.8% is the cleaner read on operating performance; roughly 2.6 percentage points of the NPAT-versus-PBT growth gap reflects the lower tax charge rather than underlying income. Second, the swing to a NZ$347.5m total return loss against a benchmark return of 5.1% is the more important durability signal for a listed investment company: capital growth, not dividend receipt alone, sustains long-term NTA per share. The income statement strengthened materially in a year the portfolio shed value.

This briefing cannot assess the composition of investment income between recurring and special dividends, nor the portfolio's stock-level performance attribution versus the benchmark.